In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival compared to placebo in patients with limited-stage small cell lung cancer ...

Medically reviewed by Susan Russell, MDLung cancer prognosis tends to be better for people diagnosed in earlier stages of the ...

At the April Sampson Cancer Center on Monday, Tom Uhlman shared his story as part of the Shine a Light on Lung Cancer ...

November is Lung Cancer Awareness Month, and early detection is in the air. According to the Centers for Disease Control, ...

CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...

Louisiana residents have one of the highest lung cancer death rates in the country, even as groundbreaking treatments in ...

Now Cambridge University Hospitals, which runs Addenbrooke’s, has been given approval by the NHS Health Research Authority (HRA) to join in the research, along with eight other UK oncology ...

Panelist discusses how the second interim overall survival data from MARIPOSA-2, presented at the European Society for ...

Jemperli plus chemotherapy demonstrated superior overall survival compared to Keytruda in advanced ... demonstrated better ...

Media ReleaseMature data in patients with a minimum follow-up of 22 months (N=21) shows excellent results, well above historical controls and ...